Company Management

Prescient Therapeutics

Biotechnology Research Au 14 employees

Employees: 14
Contacts: 2
Emails: 2
Phones: 1

prescienttherapeutics.com LinkedIn Crunchbase

Prescient Therapeutics Overview

Headquarters: Au
Phone Number: Available in AeroLeads
Website: prescienttherapeutics.com
Industry: Biotechnology Research
Employees: 14
Founded: 2014
Funding: 3.0M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Representative jobs

About Prescient Therapeutics

Prescient Therapeutics (ASX:PTX) is a clinical-stage biotech company developing personalised medicine approaches to cancer, including targeted and cellular therapies. Prescient’s technologies emanate from prestigious world class centres including Yale, Penn, Oxford and Moffitt. Targeted therapy: Prescient’s first in class targeted therapy – PTX-100 – is currently in clinical development and showing encouraging activity in diseases of unmet need. Cell therapies: Prescient owns the exclusive rights to two next-generation cell therapy platform technologies, OmniCAR and CellPryme – both with the potential to enhance CAR-T therapies and overcome challenges faced by current generation approaches

Prescient Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage
Phone contacts: 1; 25.0% coverage

Prescient Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Khang Diep	Structural Engineer at Ptx	Lyndhurst, Victoria, Australia	View
Said Sebti	Associate Director, Basic Research	Richmond, Virginia, United States	View
Ed Schoonveld	Value & Access Advisor, Author and Coach	Fort Lauderdale, Florida, United States	Email Phone
Mariam Mansour	Senior Director – Clinical Development	Greater Melbourne Area, Australia	Email